These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24604354)

  • 1. Family history of cardiovascular disease and influence on statin therapy persistence.
    Citarella A; Kieler H; Sundström A; Linder M; Wettermark B; Berglind IA; Andersen M
    Eur J Clin Pharmacol; 2014 Jun; 70(6):701-7. PubMed ID: 24604354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of baseline low-density lipoprotein cholesterol values on statin therapy persistence.
    Citarella A; Linder M; Kieler H; Berglind IA; Sundström A; Wettermark B; Andersen M
    Eur J Clin Pharmacol; 2016 Mar; 72(3):349-57. PubMed ID: 26671240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the high-risk strategy to prevent cardiovascular disease equitable? A pharmacoepidemiological cohort study.
    Wallach-Kildemoes H; Diderichsen F; Krasnik A; Lange T; Andersen M
    BMC Public Health; 2012 Aug; 12():610. PubMed ID: 22863326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term persistence with statin therapy: a nationwide register study in Finland.
    Helin-Salmivaara A; Lavikainen P; Korhonen MJ; Halava H; Junnila SY; Kettunen R; Neuvonen PJ; Martikainen JE; Ruokoniemi P; Saastamoinen LK; Virta L; Huupponen R
    Clin Ther; 2008; 30 Pt 2():2228-40. PubMed ID: 19281917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence to statin treatment: A cohort study in Lithuania.
    Kirilova K; Trečiokienė I; Bratčikovienė N; Qvarnström M; Wettermark B
    Basic Clin Pharmacol Toxicol; 2024 Jul; 135(1):43-51. PubMed ID: 38682475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world evaluation of the impact of statin intensity on adherence and persistence to therapy: A Scottish population-based study.
    Rezende Macedo do Nascimento RC; Mueller T; Godman B; MacBride Stewart S; Hurding S; de Assis Acurcio F; Guerra Junior AA; Alvares Teodoro J; Morton A; Bennie M; Kurdi A
    Br J Clin Pharmacol; 2020 Dec; 86(12):2349-2361. PubMed ID: 32353163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin adherence is lower in primary than secondary prevention: A national follow-up study of new users.
    Sigglekow F; Horsburgh S; Parkin L
    PLoS One; 2020; 15(11):e0242424. PubMed ID: 33211724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database.
    Vinogradova Y; Coupland C; Brindle P; Hippisley-Cox J
    BMJ; 2016 Jun; 353():i3305. PubMed ID: 27353261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refill adherence and persistence to lipid-lowering medicines in patients with type 2 diabetes: A nation-wide register-based study.
    Karlsson SA; Hero C; Eliasson B; Franzén S; Svensson AM; Miftaraj M; Gudbjörnsdottir S; Eeg-Olofsson K; Andersson Sundell K
    Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1220-1232. PubMed ID: 28799214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of statin discontinuation on mortality in patients with rheumatoid arthritis: a population-based study.
    De Vera MA; Choi H; Abrahamowicz M; Kopec J; Lacaille D
    Arthritis Care Res (Hoboken); 2012 Jun; 64(6):809-16. PubMed ID: 22467274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching, Persistence and Adherence to Statin Therapy: a Retrospective Cohort Study Using the Australian National Pharmacy Data.
    Talic S; Marquina C; Ofori-Asenso R; Petrova M; Liew D; Owen AJ; Lybrand S; Thomson D; Ilomaki J; Zomer E; Ademi Z
    Cardiovasc Drugs Ther; 2022 Oct; 36(5):867-877. PubMed ID: 34097194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France.
    Giral P; Neumann A; Weill A; Coste J
    Eur Heart J; 2019 Nov; 40(43):3516-3525. PubMed ID: 31362307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence With Statins in Primary Prevention of Cardiovascular Disease: Findings From a Cohort of Spanish Workers.
    Malo S; Aguilar-Palacio I; Feja C; Menditto E; Lallana MJ; Andrade E; Casasnovas JA; Rabanaque MJ
    Rev Esp Cardiol (Engl Ed); 2018 Jan; 71(1):26-32. PubMed ID: 28473266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to preventive statin therapy according to socioeconomic position.
    Wallach-Kildemoes H; Andersen M; Diderichsen F; Lange T
    Eur J Clin Pharmacol; 2013 Aug; 69(8):1553-63. PubMed ID: 23588558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin adherence and risk of acute cardiovascular events among women: a cohort study accounting for time-dependent confounding affected by previous adherence.
    Lavikainen P; Helin-Salmivaara A; Eerola M; Fang G; Hartikainen J; Huupponen R; Korhonen MJ
    BMJ Open; 2016 Jun; 6(6):e011306. PubMed ID: 27259530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low use of statins for secondary prevention in primary care: a survey in a northern Swedish population.
    Nilsson G; Samuelsson E; Söderström L; Mooe T
    BMC Fam Pract; 2016 Aug; 17(1):110. PubMed ID: 27515746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies.
    Awad K; Mohammed M; Zaki MM; Abushouk AI; Lip GYH; Blaha MJ; Lavie CJ; Toth PP; Jukema JW; Sattar N; Banach M;
    BMC Med; 2021 Jun; 19(1):139. PubMed ID: 34154589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time trends in statin use and incidence of recurrent cardiovascular events in secondary prevention between 1999 and 2013: a registry-based study.
    Laleman N; Henrard S; van den Akker M; Goderis G; Buntinx F; Van Pottelbergh G; Vaes B
    BMC Cardiovasc Disord; 2018 Nov; 18(1):209. PubMed ID: 30400778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of lipid-lowering therapy and factors affecting regularity of statin intake in patients with cardiovascular disease enrolled in the PROFILE registry.
    Gaisenok O; Martsevich S; Tripkosh S; Lukina Y
    Rev Port Cardiol; 2015 Feb; 34(2):111-6. PubMed ID: 25660463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.